Initially, we identified both monocytes (CD14+) and pDC as cell populations which expressed significantly more ICAM-1 than NK cells, CD4+ and CD8+ T cells (Fig. 7A), therefore, we hypothesized that these two cell types may act as key regulators of CVA21-mediated anti-tumor immunity. Here, CD8A is linked to neoplasm.